Page last updated: 2024-09-03

imatinib mesylate and Elevated Cholesterol

imatinib mesylate has been researched along with Elevated Cholesterol in 6 studies

Research

Studies (6)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (33.33)	29.6817
2010's	3 (50.00)	24.3611
2020's	1 (16.67)	2.80

Authors

Authors	Studies
Abdelaziz, RR; Ashry, NA; Suddek, GM	1
Aguiar, JM; Brümmendorf, TH; Cortes, JE; Dimitrov, S; Durand, JB; Fly, KD; Gambacorti-Passerini, C; Jean Khoury, H; Kantarjian, H; Leip, E; Lipton, JH; Matczak, E; Mauro, MJ; Pavlov, D; Shapiro, M	1
Blank, SD; Butrynski, JE; Corless, CL; Dressel, DM; Ebrahim, KS; Heinrich, MC; Hornick, JL; Long, KB	1
Alimena, G; Breccia, M	1
Aaltola, EM; Buchdunger, E; Koskinen, PK; Krebs, R; Laitinen, O; Lemström, KB; Sihvola, RK; Tikkanen, JM	1
Alitalo, K; Bäckström, G; Bergqvist, D; Brüggen, J; Buchdunger, E; Carlsson, M; Heldin, CH; Hiltunen, MO; Leppänen, O; Ostman, A; Rissanen, TT; Rutanen, J; Sjöblom, T; Turunen, MP; Ylä-Herttuala, S	1

Reviews

1 review(s) available for imatinib mesylate and Elevated Cholesterol

Article	Year
Pleural/pericardic effusions during dasatinib treatment: incidence, management and risk factors associated to their development. Expert opinion on drug safety, 2010, Volume: 9, Issue:5 Topics: Aged; Antineoplastic Agents; Autoimmune Diseases; Benzamides; Cardiovascular Diseases; Clinical Trials as Topic; Comorbidity; Dasatinib; Disease Management; Drug Administration Schedule; Drug Eruptions; Humans; Hypercholesterolemia; Imatinib Mesylate; Incidence; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukocyte Count; Pericardial Effusion; Piperazines; Pleural Effusion; Protein Kinase Inhibitors; Pyrimidines; Risk Factors; Thiazoles; Treatment Outcome	2010

Article

Year

Pleural/pericardic effusions during dasatinib treatment: incidence, management and risk factors associated to their development.

Expert opinion on drug safety, 2010, Volume: 9, Issue:5

Topics: Aged; Antineoplastic Agents; Autoimmune Diseases; Benzamides; Cardiovascular Diseases; Clinical Trials as Topic; Comorbidity; Dasatinib; Disease Management; Drug Administration Schedule; Drug Eruptions; Humans; Hypercholesterolemia; Imatinib Mesylate; Incidence; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukocyte Count; Pericardial Effusion; Piperazines; Pleural Effusion; Protein Kinase Inhibitors; Pyrimidines; Risk Factors; Thiazoles; Treatment Outcome

2010

Trials

1 trial(s) available for imatinib mesylate and Elevated Cholesterol

Article	Year
Long-term evaluation of cardiac and vascular toxicity in patients with Philadelphia chromosome-positive leukemias treated with bosutinib. American journal of hematology, 2016, Volume: 91, Issue:6 Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Aniline Compounds; Cardiotoxicity; Female; Humans; Hypercholesterolemia; Hyperlipidemias; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Nitriles; Protein Kinase Inhibitors; Quinolines; Retrospective Studies; Risk Factors; Vascular Diseases; Young Adult	2016

Article

Year

Long-term evaluation of cardiac and vascular toxicity in patients with Philadelphia chromosome-positive leukemias treated with bosutinib.

American journal of hematology, 2016, Volume: 91, Issue:6

Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Aniline Compounds; Cardiotoxicity; Female; Humans; Hypercholesterolemia; Hyperlipidemias; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Nitriles; Protein Kinase Inhibitors; Quinolines; Retrospective Studies; Risk Factors; Vascular Diseases; Young Adult

2016

Other Studies

4 other study(ies) available for imatinib mesylate and Elevated Cholesterol

Article	Year
The potential effect of imatinib against hypercholesterolemia induced atherosclerosis, endothelial dysfunction and hepatic injury in rabbits. Life sciences, 2020, 02-15, Volume: 243 Topics: Animals; Aorta; Atherosclerosis; Body Weight; C-Reactive Protein; Cholesterol, Dietary; Diet; Endothelium, Vascular; Enzymes; Hypercholesterolemia; Imatinib Mesylate; Lipids; Liver; Male; Rabbits	2020
Primary extragastrointestinal stromal tumor of the pleura: report of a unique case with genetic confirmation. The American journal of surgical pathology, 2010, Volume: 34, Issue:6 Topics: Anoctamin-1; Antineoplastic Agents; Atrial Fibrillation; Benzamides; Chloride Channels; Depression; Gastrointestinal Stromal Tumors; Humans; Hypercholesterolemia; Hypertension; Imatinib Mesylate; Immunohistochemistry; Male; Membrane Proteins; Middle Aged; Mutation; Neoplasm Proteins; Neoplasm Recurrence, Local; Piperazines; Pleural Neoplasms; Polymerase Chain Reaction; Proto-Oncogene Proteins c-kit; Pyrimidines	2010
Platelet-derived growth factor receptor inhibition reduces allograft arteriosclerosis of heart and aorta in cholesterol-fed rabbits. Transplantation, 2003, Feb-15, Volume: 75, Issue:3 Topics: Animals; Antineoplastic Agents; Aorta, Thoracic; Aortic Diseases; Benzamides; Cholesterol, Dietary; Coronary Artery Disease; Female; Graft Survival; Heart Transplantation; Hypercholesterolemia; Imatinib Mesylate; Incidence; Macrophages; Piperazines; Platelet-Derived Growth Factor; Pyrimidines; Rabbits; Receptors, Platelet-Derived Growth Factor; Transplantation, Homologous	2003
Oral imatinib mesylate (STI571/gleevec) improves the efficacy of local intravascular vascular endothelial growth factor-C gene transfer in reducing neointimal growth in hypercholesterolemic rabbits. Circulation, 2004, Mar-09, Volume: 109, Issue:9 Topics: Adenoviridae; Administration, Oral; Animals; Arteries; Benzamides; Cell Division; Cell Movement; Combined Modality Therapy; Endothelium, Vascular; Enzyme Inhibitors; Gene Transfer Techniques; Genetic Vectors; Hypercholesterolemia; Imatinib Mesylate; Macrophages; Muscle, Smooth, Vascular; Piperazines; Pyrimidines; Rabbits; Receptors, Platelet-Derived Growth Factor; Tunica Intima; Tunica Media; Vascular Endothelial Growth Factor C	2004